Great West Life Assurance CO Cytom X Therapeutics, Inc. Transaction History

Great West Life Assurance CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.87 - $7.39 $10,151 - $19,383	-2,623 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$6.55 - $8.83 $2,266 - $3,055	-346 Reduced 11.65%	2,623 $17,000
Q3 2020 Nov 13, 2020	BUY	$6.55 - $8.83 $2,266 - $3,055	346 Added 13.19%	2,969 $19,000
Q4 2019 Feb 11, 2020	BUY	$5.17 - $8.91 $13,560 - $23,370	2,623 New	2,623 $21,000
Q3 2019 Oct 25, 2019	SELL	$7.38 - $12.25 $36,479 - $60,551	-4,943 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$21.38 - $29.68 $67,197 - $93,284	3,143 Added 174.61%	4,943 $113,000
Q3 2017 Nov 09, 2017	BUY	$13.53 - $18.17 $24,354 - $32,706	1,800	1,800 $32,000

50.2M

22.3K

22.9K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $77.8M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.